Cormorant Asset Management, LP — Form 4 insider transactions
Cormorant Asset Management, LP — Full 13F portfolio →
Buys and sells reported on SEC Form 4 — filed within two business days of each trade when a filer's ownership in a stock crosses 10%. This is the fastest public window into what the manager is doing.
| Transaction date | Activity | Security | Shares | Price | Total | Filing |
|---|---|---|---|---|---|---|
| 2026-10-29 | Sell | Corbus Pharmaceuticals Holdings, Inc. | 425,000 | $4.10 | $1,742,755 | SEC filing |
| 2026-08-10 | Buy | BlossomHill Therapeutics, Inc. | 312,500 | $16.00 | $5,000,000 | SEC filing |
| 2026-08-10 | Conversion | BlossomHill Therapeutics, Inc. | 1,701,541 | — | — | SEC filing |
| 2026-08-10 | Conversion | BlossomHill Therapeutics, Inc. | 1,599,993 | — | — | SEC filing |
| 2026-04-28 | Sell | BRIGHT MINDS BIOSCIENCES INC. | 109,331 | $89.50 | $9,785,124 | SEC filing |
How Form 4 differs from 13F
13F filings are quarterly snapshots, up to 45 days late. Form 4 is transaction-level and lands within two business days — but only covers stocks where the filer reports beneficial ownership above 10%. Pair the two: 13F for the whole portfolio, Form 4 for what the largest holders are doing right now.